Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study
Louisa Degenhardt, Nicholas Lintzeris, Gabrielle Campbell, Raimondo Bruno, Milton Cohen, Michael Farrell, Wayne D Hall
Drug and Alcohol Dependence | ELSEVIER IRELAND LTD | Published : 2015
BACKGROUND: There is increasing debate about cannabis use for medical purposes, including for symptomatic treatment of chronic pain. We investigated patterns and correlates of cannabis use in a large community sample of people who had been prescribed opioids for chronic non-cancer pain. METHODS: The POINT study included 1514 people in Australia who had been prescribed pharmaceutical opioids for chronic non-cancer pain. Data on cannabis use, ICD-10 cannabis use disorder and cannabis use for pain were collected. We explored associations between demographic, pain and other patient characteristics and cannabis use for pain. RESULTS: One in six (16%) had used cannabis for pain relief, 6% in the p..View full abstract
Awarded by Australian National Health and Medical Research Council (NHMRC)
Awarded by NHMRC research fellowships
This study received funding from the Australian National Health and Medical Research Council (NHMRC, #1022522). LD and WH are supported by NHMRC research fellowships (#1041472, #569738). The National Drug and Alcohol Research Centre at UNSW Australia is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. Cerissa Papanastasiou was supported by funding provided by the Victorian Drug Law Enforcement Fund. The funder had no role in the design, conduct or interpretation of this study.